Cargando…
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases
BACKGROUND: In colorectal cancer (CRC), the liver is the most common site of metastasis. Surgical resection represents the standard therapy for patients with colorectal liver metastases (CRLM). However, 5-year survival rates after resection do not exceed 50%, and despite existing preoperative strati...
Autores principales: | Loosen, Sven H., Tacke, Frank, Binnebosel, Marcel, Leyh, Catherine, Vucur, Mihael, Heitkamp, Florian, Schoening, Wenzel, Ulmer, Tom F., Alizai, Patrick H., Trautwein, Christian, Koch, Alexander, Longerich, Thomas, Roderburg, Christoph, Neumann, Ulf P., Luedde, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007468/ https://www.ncbi.nlm.nih.gov/pubmed/29930748 http://dx.doi.org/10.18632/oncotarget.25471 |
Ejemplares similares
-
High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma
por: Loosen, Sven H, et al.
Publicado: (2019) -
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
por: Loosen, Sven H., et al.
Publicado: (2020) -
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020) -
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2017) -
Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer
por: Pombeiro, Ines, et al.
Publicado: (2018)